1,575 Views

To Earn CE for this Session: Watch the on-demand recording in its entirety to unlock the CE quiz. Then click here to complete the CE quiz for this session.

Specialty Symposium

Oncology

New Developments in the Treatment of Canine B-cell Lymphoma

Wednesday, June 22, 2022

8:30 AM – 10:45 AM CT

Location: ACC 18CD

CE: 2

Sponsored by

Primary Presenter(s)

CL

Cheryl A. London, DVM, PhD, DACVIM (Oncology)

Anne Engen and Dusty Professor of Comparative Oncology, Associate Dean for Research and Graduate Education
Tufts University, Cummings School of Veterinary Medicine
North Grafton, Massachusetts, United States

Slides

Co-Presenter(s)

Nicola Mason, BVetMed, PhD, DACVIM (SAIM),

Professor of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania, United States

Dr. Cheryl London and Dr. Nicola Mason will be presenting their current research and future developments for the treatment of B cell lymphoma in dogs. Taking a novel approach, integrating minimal doses of chemotherapy, immunotherapy, and engineered T cells, they will be reporting their findings and how this will impact the treatment of B cell lymphoma. They will cover their current outcomes, response rates, and plans for integrating these novel treatments into more patients in the future.

Learning Objectives:

Understanding the role and impact of immunotherapy in canine lymphoma
Recognizing that minimal dose chemotherapy can be effective in the treatment of B cell lymphoma
Understanding the development and implementation of CAR T-cells for the treatment of lymphoma